Due to the persistence of the COVID-19 pandemic, research and development around vaccines, drugs and diagnostics are still a major topic around the world.
One of those development projects is performed by an alliance of UC Davis Health and SpectraPass LLC in the US. The developed MALDI-TOF-MS-based diagnostic tool enables high-throughput screening for COVID-19 and has entered the next stage of development.
In April 2021 the team published a paper on COVID-19 diagnosis, combining the advantages of Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF)—mass spectrometry (MS) with machine learning (ML). They reported rapid COVID-19 tests with results within 20 minutes, without sacrificing test accuracy or sensitivity. This ground-breaking outcome offers immense potential for rapid screening of many individuals, which would be an important step in societies re-opening.
The study started in December 2021 and aims to verify those results with a larger number of tests.
Read the entire paper HERE
Read the snapshot of the innovation HERE
Find out more about SpectraPass HERE
To ensure robust calibration performance and accuracy in mass spectrometry, Polymer Factory (publ) has developed SpheriCal® - an MS calibrant platform targeted to be the best-in-class solution. Polymer Factory’s SpheriCal® can be used both as an internal calibrant as well as for instrument calibration or tuning, and can be purchased in a broad range of molecular weights to cover every need of the end-user.